Frazier Management LLC Replimune Group, Inc. Transaction History

Frazier Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$15.24 - $29.75 $9.92 Million - $19.4 Million	-650,862 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$25.43 - $34.25 $4.04 Million - $5.44 Million	158,864 Added 32.29%	650,862 $17.6 Million
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $14.3 Million - $19.5 Million	491,998 New	491,998 $14.6 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.